Roivant Sciences Ltd.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophos…
Biotechnology
GB, London [HQ]
Balance Sheet
5 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Assets | 1,387.00 | 2,477.00 | 2,589.00 | 2,585.00 | 2,389.00 | |
|
Current
|
1,185.00 | 2,219.00 | 2,186.00 | 2,146.00 | 1,798.00 | |
| Cash And Equivalents | 849.00 | 2,185.00 | 2,055.00 | 2,060.00 | 1,676.00 | |
| Assets | 1,387.00 | 2,477.00 | 2,589.00 | 2,585.00 | 2,389.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | |
| Inventory | - - | - - | 63.00 | -16.00 | 2.00 | |
| Short Term Investments | - - | - - | - - | 13.00 | 15.00 | |
| Other Current Assets | 324.00 | 18.00 | 54.00 | 82.00 | 121.00 | |
|
Non Current
|
202.00 | 257.00 | 402.00 | 438.00 | 591.00 | |
| Property, Plant, Equipment (Net) | 11.00 | 73.00 | 77.00 | 86.00 | 92.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | 144.00 | |
| Goodwill | - - | - - | - - | - - | - - | |
| Long Term Investments | 169.00 | 177.00 | 289.00 | 325.00 | 304.00 | |
| Other Non Current Assets | 21.00 | 6.00 | 36.00 | 25.00 | 49.00 | |
| Liabilities | 450.00 | 368.00 | 527.00 | 546.00 | 782.00 | |
|
Current
|
211.00 | 92.00 | 218.00 | 184.00 | 272.00 | |
| Accounts Payable | 4.00 | 6.00 | 3.00 | 15.00 | 4.00 | |
| Short Term Debt | 21.00 | 7.00 | 12.00 | 11.00 | 52.00 | |
| Deferred Revenue | 1.00 | 3.00 | 5.00 | 10.00 | 167.00 | |
| Tax Payable | - - | 1.00 | - - | - - | - - | |
| Other Current Liabilities | 182.00 | 70.00 | 180.00 | 128.00 | 15.00 | |
|
Non Current
|
239.00 | 276.00 | 308.00 | 339.00 | 509.00 | |
| Long Term Debt | 121.00 | 108.00 | 232.00 | 272.00 | 428.00 | |
| Leasing Obligations | - - | 64.00 | 74.00 | 73.00 | 65.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | |
| Other Non Current Liabilities | 117.00 | 167.00 | 76.00 | 53.00 | 80.00 | |
| Equity | 937.00 | 2,108.00 | 2,062.00 | 2,443.00 | 2,057.00 | |
| Stockholders' Equity | 716.00 | 2,032.00 | 1,797.00 | 2,038.00 | 1,607.00 | |
| Retained Earnings | -2,309.00 | -1,109.00 | -1,918.00 | -2,763.00 | -3,772.00 | |
| Common Stock | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | - - | |
| Profit | -1,041.00 | 1,200.00 | -900.00 | -924.00 | -1,230.00 | |
| Dividends | - - | - - | - - | - - | - - | |
| Minority Interest | 220.00 | 76.00 | 264.00 | 404.00 | 449.00 | |
| Other Stockholders' Equity | 3,024.00 | 3,143.00 | 3,714.00 | 4,803.00 | 5,382.00 | |
| Loss Other Compr. Income | 2.00 | -2.00 | 1.00 | - - | -2.00 |